WDR88: A Non-Coding RNA Molecule Regulating Wnt/Fz Signaling (G126248)

Target Name: WDR88

NCBI ID: G126248

WDR88

WDR88: A Non-Coding RNA Molecule Regulating Wnt/Fz Signaling

WDR88, also known as WDR88-1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of gene expression in the Wnt/Fz signaling pathway, which plays a crucial role in the development and maintenance of tissues and organs during development and throughout life. WDR88 has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion.

The Wnt/Fz signaling pathway is a complex regulatory network that is involved in the development and maintenance of tissues and organs during development and throughout life. It is composed of a series of proteins that form a complex structure called the Fz-1/2 complex. The Fz-1 protein is a transcription factor that binds to specific DNA sequences, while the Fz-2 protein is a dimerization factor that protects the Fz-1 protein from degradation. The Fz-1/2 complex plays a crucial role in the regulation of gene expression by binding to specific DNA sequences and regulating the activity of the Fz-1 protein.

WDR88 is a non-coding RNA molecule that has been shown to be involved in the regulation of various cellular processes. It is a key regulator of gene expression in the Wnt/Fz signaling pathway, which plays a crucial role in the development and maintenance of tissues and organs during development and throughout life.

WDR88 has been shown to be involved in the regulation of cell adhesion, migration, and invasion. It has been shown to play a key role in the development of the neural tube, which forms the baby's brain and spinal cord. WDR88 has also been shown to be involved in the regulation of the production of extracellular matrix (ECM) components, such as collagen.

In addition to its role in the regulation of cellular processes, WDR88 has also been shown to be involved in the regulation of stem cell proliferation. It has been shown to play a role in the regulation of the stem cell cycle, including the G1 phase and the G0 phase.

WDR88 has also been shown to be involved in the regulation of tissue repair and regeneration. It has been shown to play a role in the regulation of the Wnt signaling pathway in the regulation of tissue repair and regeneration.

WDR88 has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. It has been shown to play a role in the regulation of the TGF-β pathway, which is involved in the regulation of cell signaling pathways and has been implicated in a variety of diseases, including cancer.

WDR88 has also been shown to be involved in the regulation of the microtubule dynamics. It has been shown to play a role in the regulation of microtubule dynamics, which is involved in the movement of cells and the transport of organelles within the cell.

In conclusion, WDR88 is a non-coding RNA molecule that has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. It is a key regulator of the Wnt/Fz signaling pathway and has been shown to play a role in the development and maintenance of tissues and organs during development and throughout life. Its potential as a drug target and biomarker makes it an attractive target for future research.

Protein Name: WD Repeat Domain 88

The "WDR88 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR88 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets